Jill Beyer

3.6k total citations · 1 hit paper
62 papers, 2.8k citations indexed

About

Jill Beyer is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Jill Beyer has authored 62 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 25 papers in Infectious Diseases and 20 papers in Hepatology. Recurrent topics in Jill Beyer's work include Hepatitis C virus research (20 papers), HIV/AIDS drug development and treatment (17 papers) and Hepatitis B Virus Studies (13 papers). Jill Beyer is often cited by papers focused on Hepatitis C virus research (20 papers), HIV/AIDS drug development and treatment (17 papers) and Hepatitis B Virus Studies (13 papers). Jill Beyer collaborates with scholars based in United States, United Kingdom and Japan. Jill Beyer's co-authors include Robert K. Flamm, Virginia D. Shortridge, Shinji Tanaka, James Versalovic, Dee Shortridge, David Y. Graham, Dena M. Hensey, Prabhavathi Fernandes, Dwight J. Hardy and Thomas Reisch and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Jill Beyer

62 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori

1996 407 citations James Versalovic, Dee Shortridge et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jill Beyer United States	31	1.5k	938	807	716	533	62	2.8k
M Gobernado Spain	28	1.9k 1.3×	1.2k 1.3×	263 0.3×	588 0.8×	191 0.4×	147	3.1k
Aristine Cheng Taiwan	26	938 0.6×	791 0.8×	230 0.3×	248 0.3×	198 0.4×	98	1.9k
Chen‐Hsiang Lee Taiwan	29	790 0.5×	777 0.8×	833 1.0×	74 0.1×	147 0.3×	145	2.5k
Geraldine S. Hall United States	24	1.4k 1.0×	1.1k 1.2×	307 0.4×	70 0.1×	545 1.0×	46	2.4k
Emily Henkle United States	20	3.2k 2.2×	738 0.8×	157 0.2×	416 0.6×	286 0.5×	47	3.6k
Jang Wook Sohn South Korea	29	991 0.7×	781 0.8×	312 0.4×	121 0.2×	71 0.1×	140	2.3k
Miguel Salavert Spain	29	1.7k 1.2×	1.6k 1.8×	489 0.6×	62 0.1×	132 0.2×	202	3.0k
Richard Odame Phillips Ghana	31	2.2k 1.5×	1.3k 1.4×	376 0.5×	353 0.5×	1.0k 1.9×	180	3.5k
Kamal Hamed United States	29	978 0.7×	816 0.9×	155 0.2×	131 0.2×	87 0.2×	117	2.2k
J Tollemar Sweden	30	1.7k 1.2×	1.7k 1.8×	530 0.7×	94 0.1×	177 0.3×	87	3.1k

Countries citing papers authored by Jill Beyer

Since Specialization

Citations

This map shows the geographic impact of Jill Beyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Beyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Beyer more than expected).

Fields of papers citing papers by Jill Beyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Beyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Beyer. The network helps show where Jill Beyer may publish in the future.

Co-authorship network of co-authors of Jill Beyer

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Beyer. A scholar is included among the top collaborators of Jill Beyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Beyer. Jill Beyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schnell, Gretja, Preethi Krishnan, Rakesh Tripathi, et al.. (2018). Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir. PLoS ONE. 13(10). e0205186–e0205186. 10 indexed citations

Ng, Teresa I., Rakesh Tripathi, Gretja Schnell, et al.. (2016). Analysis of HCV Genotype 2 and 3 Variants in Patients Treated with Combination Therapy of Next Generation HCV Direct-Acting Antiviral Agents ABT-493 and ABT-530. Journal of Hepatology. 64(2). S409–S410. 6 indexed citations

Randolph, John T., Peggy Huang, Rolf Wagner, et al.. (2013). High potency improvements to weak aryl uracil HCV polymerase inhibitor leads. Bioorganic & Medicinal Chemistry Letters. 23(15). 4367–4369. 5 indexed citations

Qazi, Yureeda, Andrea Cruzat, Neda Baniasadi, et al.. (2011). Early Effects of Contact Lens Wear on Immune Cell Density of the Ocular Surface: Preliminary Results of a Laser In Vivo Confocal Microscopy Study. Investigative Ophthalmology & Visual Science. 52(14). 6551–6551. 2 indexed citations

Tanz, Robert R., Stanford T. Shulman, Virginia D. Shortridge, et al.. (2004). Community-Based Surveillance in the United States of Macrolide-Resistant Pediatric Pharyngeal Group A Streptococci during 3 Respiratory Disease Seasons. Clinical Infectious Diseases. 39(12). 1794–1801. 53 indexed citations

Doktor, Stella Z., Virginia D. Shortridge, Jill Beyer, & Robert K. Flamm. (2003). Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations. Diagnostic Microbiology and Infectious Disease. 49(1). 47–52. 18 indexed citations

Nilius, Angela M., Linus L. Shen, Laurel S. Almer, et al.. (2003). In Vitro Antibacterial Potency and Spectrum of ABT-492, a New Fluoroquinolone. Antimicrobial Agents and Chemotherapy. 47(10). 3260–3269. 100 indexed citations

Almer, Laurel S., Virginia D. Shortridge, Angela M. Nilius, et al.. (2002). Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagnostic Microbiology and Infectious Disease. 43(3). 225–232. 49 indexed citations

Zhong, Ping, Zhensheng Cao, Rachel Hammond, et al.. (1999). Induction of Ribosome Methylation in MLS-Resistant Streptococcus pneumoniae by Macrolides and Ketolides. Microbial Drug Resistance. 5(3). 183–188. 43 indexed citations

10.

Shortridge, Virginia D., Gary V. Doern, Angela B. Brueggemann, Jill Beyer, & Robert K. Flamm. (1999). Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994-1995. Clinical Infectious Diseases. 29(5). 1186–1188. 140 indexed citations

11.

Grötz, K. A., Bilal Al‐Nawas, H. Duschner, et al.. (1999). Confocal Laser Scanning Microscopy: A Nondestructive Subsurface Histotomography of Healthy Human Bone. Calcified Tissue International. 65(1). 8–10. 9 indexed citations

12.

Stone, Gregory G., Dee Shortridge, Robert K. Flamm, et al.. (1997). PCR-RFLP typing of ureC from Helicobacter pylori isolated in Argentina from gastric biopsies before and after treatment with clarithromycin. Epidemiology and Infection. 118(2). 119–124. 13 indexed citations

13.

Shortridge, Virginia D., Robert K. Flamm, N Ramer, Jill Beyer, & S. Ken Tanaka. (1996). Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease. 26(2). 73–78. 103 indexed citations

14.

Stone, Gregory G., Dee Shortridge, Robert K. Flamm, et al.. (1996). Identification of a 23S rRNA Gene Mutation in Clarithromycin‐Resistant Helicobacter pylori. Helicobacter. 1(4). 227–228. 78 indexed citations

15.

Flamm, Robert K., Jill Beyer, Shinji Tanaka, & Jacob J. Clement. (1996). Kill kinetics of antimicrobial agents against Helicobacter pylori. Journal of Antimicrobial Chemotherapy. 38(4). 719–725. 15 indexed citations

16.

Versalovic, James, Dee Shortridge, Jill Beyer, et al.. (1996). Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. 40(2). 477–480. 407 indexed citations breakdown →

17.

Fernandes, Prabhavathi, et al.. (1989). Coumamidines, new broad spectrum antibiotics of the cinodine type. III. Microbiologic activity of coumamidine .GAMMA.1.. The Journal of Antibiotics. 42(4). 538–541. 5 indexed citations

18.

Hardy, Dwight J., et al.. (1988). Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. Journal of Antimicrobial Chemotherapy. 22(5). 631–636. 98 indexed citations

19.

Hardy, Dwight J., et al.. (1988). Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrobial Agents and Chemotherapy. 32(11). 1710–1719. 261 indexed citations

20.

Hørslev‐Petersen, Kim, Jill Beyer, & P. Helin. (1983). Intermittent cyclophosphamide in refractory rheumatoid arthritis.. BMJ. 287(6394). 711–712. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact